Arkolith/Insider Trading/ACLX/Form 4

Heery Christopher

CHIEF MEDICAL OFFICERArcellx, Inc. (ACLX) · full profile →Form 4 · filed Apr 28, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
1 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 28, 2026Tender(U)24K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 28, 2026Disposed to issuer(D)11K——0
Apr 28, 2026Disposed to issuer(D)44K——0
Apr 28, 2026Disposed to issuer(D)132K——0
Apr 28, 2026Disposed to issuer(D)40K——0
Apr 28, 2026Disposed to issuer(D)76K——0
Apr 28, 2026Disposed to issuer(D)60K——0
Apr 28, 2026Disposed to issuer(D)13K——0
Apr 28, 2026Disposed to issuer(D)39K——0
Apr 28, 2026Disposed to issuer(D)68K——0
Apr 28, 2026Grant(A)45K——45K
Apr 28, 2026Disposed to issuer(D)45K——0

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001789632-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML